Category: Cannabis
-
Delic Holdings (DELC.C) emerges as a psychedelics play aimed at executing real, legal business, and right now
Smallcap investors largely see the psychedelics space in one of two ways; you’re either in the ‘this may be big one day but there’s not a lot of fat on the bones just yet so I’ll wait’ camp, or the ‘fat schmat, everything is a trade and who cares about tomorrow’ camp. I’m pegged pretty…
-
![Harborside (HBOR.C) reports good Q3, 2020 financial results]()
Harborside (HBOR.C) reports good Q3, 2020 financial results
During Q3 2020, Harborside generated total gross revenues of approximately $19.6 million, representing a 21.2% sequential growth over Q2, 2020
-
![Isracann (IPOT.C) stock moves after Israel eye-balls legal rec weed]()
Isracann (IPOT.C) stock moves after Israel eye-balls legal rec weed
Five days ago, the embattled Israeli government announced “a road map to legalize cannabis within one year” creating a regulated market for adult-use marijuana.
-
![Revive (RVV.C) advances mushroom bio-tech as new regs change the game]()
Revive (RVV.C) advances mushroom bio-tech as new regs change the game
On November 11, 2020 Revive Therapeutics (RVV.C) Revive Therapeutics updated shareholders on its oral thin-film delivery system with psilocybin being developed “under a research partnership agreement with Reed Research Group out of the University of Wisconsin-Madison”. RVV is a specialty life sciences company focused on the R&D of therapeutics for medical needs and rare disorders.…
-
Pure Extracts (PULL.C) goes public with profit-focused cannabis (and mushroom) extraction business model
Yeah, I know, I know. Canadian cannabis companies are ass right now, and have been for a few years. Trust me, I’m about as out of the LP business now as I’ve ever been, but you’d also be an idiot to tar every cannabis company with the same brush, because not every deal involves growing…
-
![Harborside (HBOR.C) upgrades California grow-op, launches clone sales, pushes rev. projections higher]()
Harborside (HBOR.C) upgrades California grow-op, launches clone sales, pushes rev. projections higher
The company’s in-house brand, Harborside Farms will begin sales of clones grown at its Salinas facility at all Harborside branded locations, including Desert Hot Springs.
-
Revive Therapeutics (RVV.C) to have 10 clinical COVID-19 FDA trial sites by end of year
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks laughed uproariously at the thought that a three time loser might be relevant in 2020. Having missed on an earlier pharma focus, and come to the cannabis party a little…
-
Harborside (HBOR.C) adds to San Francisco dispensary portfolio
On October 19, 2020 Harborside (HBOR.C) announced that it has reached a definitive agreement to acquire 50.1% of FGW Haight – a California co. that has the “conditional-use approval” to operate a cannabis dispensary and related businesses in the iconic Haight Ashbury area of San Francisco, Calif.
-
![Isracann’s (IPOT.C) export strategy just got a green light]()
Isracann’s (IPOT.C) export strategy just got a green light
October 14, 2020 Isracann announced that “the government of Israel has officially enacted the legislation for the export of medical cannabis, clearing the way for sales abroad that the government expects could generate more than 1 billion shekels ($273 million) in annual revenue.”
-
![Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus]()
Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
